ArticleOncotarget2015

Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ERK signaling pathways.

Tengda Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.